fenoldopam has been researched along with Acute Disease in 8 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the safeties and efficacies of IV fenoldopam (FNP) vs sodium nitroprusside (NTP) in severe acute hypertension." | 9.08 | Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group. ( Bednarczyk, EM; Dunbar, LM; Foulke, GE; Holcslaw, TL; Panacek, EA, 1995) |
| "Fenoldopam is a dopamine receptor (DA1 selective) agonist that is a systemic and renal vasodilator." | 6.40 | Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. ( Aronson, S; Deeb, GM; Epstein, M; Levy, JH; Luther, RR; Oparil, S; Prielipp, R; Taylor, A, 1999) |
| "To compare the safeties and efficacies of IV fenoldopam (FNP) vs sodium nitroprusside (NTP) in severe acute hypertension." | 5.08 | Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group. ( Bednarczyk, EM; Dunbar, LM; Foulke, GE; Holcslaw, TL; Panacek, EA, 1995) |
| "Vasoactive compounds are known to affect intrarenal hemodynamics and gene transcription, but specific effects of fenoldopam in the setting of acute renal ischemia are not known." | 3.73 | Fenoldopam improves corticomedullary oxygen delivery and attenuates angiogenesis gene expression in acute ischemic renal injury. ( Aravindan, N; Riedel, B; Samuels, J; Shaw, A, 2006) |
| "In the case of hypertensive encephalopathy, the lowering of blood pressure is therapeutic as well as diagnostic." | 2.43 | [Antihypertensive management in acute cerebral stroke]. ( Ziliene, V, 2005) |
| "Fenoldopam is a dopamine receptor (DA1 selective) agonist that is a systemic and renal vasodilator." | 2.40 | Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. ( Aronson, S; Deeb, GM; Epstein, M; Levy, JH; Luther, RR; Oparil, S; Prielipp, R; Taylor, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caixeta, A | 1 |
| Mehran, R | 1 |
| Brienza, N | 1 |
| Giglio, MT | 1 |
| Marucci, M | 1 |
| Ziliene, V | 1 |
| Aravindan, N | 1 |
| Samuels, J | 1 |
| Riedel, B | 1 |
| Shaw, A | 1 |
| Bodmann, KF | 1 |
| Tröster, S | 1 |
| Clemens, R | 1 |
| Schuster, HP | 1 |
| Panacek, EA | 1 |
| Bednarczyk, EM | 1 |
| Dunbar, LM | 1 |
| Foulke, GE | 1 |
| Holcslaw, TL | 1 |
| Oparil, S | 1 |
| Aronson, S | 1 |
| Deeb, GM | 1 |
| Epstein, M | 1 |
| Levy, JH | 1 |
| Luther, RR | 1 |
| Prielipp, R | 1 |
| Taylor, A | 1 |
| Gretler, DD | 1 |
| Elliott, WJ | 1 |
| Moscucci, M | 1 |
| Childers, RW | 1 |
| Murphy, MB | 1 |
4 reviews available for fenoldopam and Acute Disease
| Article | Year |
|---|---|
Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Disease; Angioplasty, Balloon, Coronary; Contrast Media; Dopamine; Drug Admini | 2010 |
Preventing acute kidney injury after noncardiac surgery.
Topics: Acute Disease; Acute Kidney Injury; Atrial Natriuretic Factor; Cardiac Output; Fenoldopam; Hemodynam | 2010 |
[Antihypertensive management in acute cerebral stroke].
Topics: Acute Disease; Adult; Antihypertensive Agents; Brain Injuries; Cerebrovascular Circulation; Emergenc | 2005 |
Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises.
Topics: Acute Disease; Animals; Antihypertensive Agents; Blood Pressure; Dopamine Agonists; Fenoldopam; Huma | 1999 |
3 trials available for fenoldopam and Acute Disease
| Article | Year |
|---|---|
Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acute Disease; Aged; Aged, 80 and over; | 1993 |
Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Blood Pressure; Female; Fenoldopam; Humans; Hypertens | 1995 |
Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acute Disease; Adult; Dopamine Agents; E | 1992 |
1 other study available for fenoldopam and Acute Disease
| Article | Year |
|---|---|
Fenoldopam improves corticomedullary oxygen delivery and attenuates angiogenesis gene expression in acute ischemic renal injury.
Topics: Acute Disease; Analysis of Variance; Angiogenesis Inducing Agents; Animals; Fenoldopam; Gene Express | 2006 |